— Know what they know.
Not Investment Advice

IMRSQ OTC

IMRIS Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 54 · $626 mcap · 40M float · 0.082% daily turnover

Cash Flow Trends

Operating Cash Flow
-$11M +73.1% ▲
Capital Expenditures
$3M +71.8% ▲
5Y CAGR: -5.2%
Free Cash Flow
-$14M +72.9% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$1M +89.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2010FY2011FY2012FY2013FY2014
— Operating Activities —
Net Income-$1M-$21M-$28M-$42M-$30M
Depreciation & Amort.$4M$4M$4M$3M$3M
Stock-Based Comp.$982K$1M$2M$2M$2M
Change in Working Capital-$18M-$818K$6M-$7M$13M
Other Non-Cash Items$912K$306K$907K$3M$2M
Operating Cash Flow-$14M-$18M-$16M-$41M-$11M
— Investing Activities —
Capital Expenditures-$1M-$3M-$5M-$9M-$3M
Acquisitions (Net)-$181K$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$293K$0$0$0$0
Other Investing-$771K-$838K-$4M-$6M$7M
Investing Cash Flow-$2M-$4M-$8M-$15M$4M
— Financing Activities —
Net Debt Issuance$0$0$0$25M$500K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0-$2M$0
Financing Cash Flow$51M$1M$2M$42M$4M
Net Change in Cash$34M-$20M-$21M-$13M-$1M
Cash End of Period$60M$40M$19M$6M$5M
Free Cash Flow-$16M-$18M-$21M-$50M-$14M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms